Bafna Pharmaceuticals informs about company updates

28 May 2018 Evaluate

Pursuant to the audit conducted by Medicines and Healthcare products Regulatory Agency (MHRA), Bafna Pharmaceuticals has informed that their Facility has got Renewal approval as per the Guidelines of European Good Manufacturing Practices (EUGMP).

The above information is a part of company’s filings submitted to BSE.

 

Bafna Pharma Share Price

111.80 4.30 (4.00%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×